
About PharmaCielo
PharmaCielo is a publicly listed company based in Toronto (Canada) founded in 2014. Medicinal cannabis oil and products are produced in Colombia. PharmaCielo has raised $16.44 million across 10 funding rounds. PharmaCielo has completed 2 acquisitions, including Creso Pharma and Ubiquo Telemedicina. Its chief executive, as recorded, is Marc Lustig. PharmaCielo offers products and services including CBD Isolate, Medicinal Flower, and Cannabis Extracts. Its focus areas include Food and Agriculture Tech, Crop Tech, Indoor Farming and Hydroponics. Its competitors include Canopy Growth, Organigram and Cannara Biotech; 1 of its 3 listed competitors has raised funding.
Company details
PharmaCielo was founded in 2014 and is headquartered in Toronto, Canada. Operations focus on the cultivation and marketing of medicinal cannabis in Colombia, where proprietary strains are grown under controlled indoor environments. Cannabis flowers are processed to extract oil and manufacture pharmaceutical-grade products for the health sector.
- Headquarters Toronto, Canada
- Stage Public
- SectorsAgriculture
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website pharmacielo.com
- Social LinkedIn X Instagram YouTube
- Legal Name Pharmacielo Ltd.
- Annual Revenue$1.82 M (USD)-17.31as on Mar 31, 2026
- Net Profit-$2.57 M (USD)59.3as on Mar 31, 2026
- EBITDA-$1.79 M (USD)22.46as on Mar 31, 2026
- Total Equity Funding$16.44M (USD)
in 10 rounds
- Latest Funding Round$10M (USD), Post-IPO
Nov 2020
- Investments & AcquisitionsCreso Pharma
& 1 more
Products & Services of PharmaCielo
PharmaCielo offers a comprehensive portfolio of products and services, including CBD Isolate, Medicinal Flower, and Cannabis Extracts.
Pure CBD refined for precise medicinal and pharmaceutical applications.
High-quality cannabis flower grown for reliable pharmaceutical use.
Processed extracts for consistent, safe medicinal applications.
Apps and channels of PharmaCielo
its YouTube channel PharmaCielo Ltd. has 261 subscribers and 9 videos.
Videos from PharmaCielo
The most watched videos on PharmaCielo's YouTube channel, PharmaCielo Ltd. (261 subscribers). Click a video to play it here.
More on PharmaCielo Ltd..
Funding Insights of PharmaCielo
PharmaCielo has successfully raised a total of $16.44M across 10 strategic funding rounds. The most recent funding activity was a Post-IPO round of $10 million completed in November 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $16.44M
- Total Rounds 10
- Last Round Post-IPO β $10M
- First Round $686,250
(May 2015)
All 10 funding rounds of PharmaCielo with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2020 | $10M | Post-IPO | β | β | β |
| Apr 2020 | $5.64M | Post-IPO | β | β | β |
| Feb 2019 | $6.32M | Post-IPO | β | β | β |
| Dec 2017 | $1.96M | Series A | β | β | β |
| Jul 2017 | $2.96M | Series A | β | β | β |
| May 2017 | $3.71M | Series A | β | β | β |
| Jun 2016 | $116,500 | Series A | β | β | β |
| May 2016 | $4.02M | Series A | β | β | β |
| Feb 2016 | $2.98M | Series A | β | β | β |
| May 2015 | $686,250 | Seed | β | β | β |
People of PharmaCielo
20 people are tracked at PharmaCielo (8 in leadership, 2 in board & advisors, 10 in team).
| Name | Role | Group |
|---|---|---|
Marc Lustig | CEO | Leadership |
Andrés Felipe Botero | Chief Operating Officer, PharmaCielo Colombia | Leadership |
Bill Petron | CEO & Chairman of the Board | Leadership |
Ian D. Atacan | Chief Financial Officer | Leadership |
Delon H. | President, Global Head Health & Innovation | Leadership |
Juan Camilo Esguerra | Chief Legal Officer And Vice President Of Government Affairs | Leadership |
Andres Felipe Botero Diaz | Chief Operating Officer | Leadership |
Pablo Cuartas | Head Of Operations Planning | Leadership |
Doug Bache | Director & Audit Committee Chair | Board & advisors |
Will Nicholas | Director | Board & advisors |
María Cristina Gil González | Operaria Industrial | Team |
Henning von Koss | Unknown Role | Team |
Oscar Eduardo Soto Castañeda | Ingeniero De Mantenimiento | Team |
Luisa Fernanda Serna Cárdenas | Jefe De Control Interno | Team |
Mabel Manrique Garcia | Coordinadora De Procesos | Team |
Maria Camila Velez | Jefe De Logística | Team |
Carmenza Patiño | Analista De Compras | Team |
Robert Gavidge | Finance Analyst | Team |
Luis Felipe Vidal Jiménez | Jefe De Planeación Financiera | Team |
Jose Pablo Saldarriaga Franco | Supply Chain Manager | Team |
Complete people profiles for PharmaCielo
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of PharmaCielo
PharmaCielo is a publicly listed company on the OTC with ticker symbol PCLOF in USA, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date02 Feb 2018
- Listed onTSX-V: PCLO
- Listed entityPHARMACIELO LTD.
- Exchange sectorProcess industries
- ISINCA71716K1012
- Share price$0.04 (+21.79% on the day) · 2026-05-11
- Market capitalisation$6.8M
- EPS (diluted, trailing year)$-0.02
- Volume (last session)10,000
- Analyst consensusNo rating
Financials of PharmaCielo
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $1.8M | -$2.6M | -$1.8M |
| 2024 | $2.2M | -$6.3M | -$2.3M |
| 2023 | $1.2M | -$12.3M | -$6.9M |
| 2022 | $3.9M | -$10.7M | -$6.3M |
| 2021 | $1.5M | -$21.1M | -$17.8M |
Detailed financial statements for PharmaCielo
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PharmaCielo
PharmaCielo has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Creso Pharma and Ubiquo Telemedicina.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Cannabinoid therapeutics are developed for human and veterinary health applications. | cresopharma.com | Perth, Australia | 2015 | Jun 2019 | $85.2M | |
Web platforms for telemedicine, workflow, and image management are provided. | ubiquotelemedicina.com.co | Medellin, Colombia | 2010 | Apr 2018 | $1.19M |
Complete acquisition details for PharmaCielo
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of PharmaCielo
6 dated milestones of PharmaCielo across 6 years, from founding to its latest funding, stage changes and deals.
- Founded PharmaCielo is founded.
- Funding First funding round of $686K.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Ubiquo Telemedicina.
- Acquisition Acquires Creso Pharma.
- Funding Latest funding round, Post-IPO, of $10.0M.
Competitors of PharmaCielo
PharmaCielo has 3 listed competitors in our database, 1 of them funded. They include Canopy Growth, Organigram and Cannara Biotech.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| canopygrowth.com | 2013 | Smiths Falls, Canada | 170 | Cannabis products are provided to support consumer wellness and health. | ||
| organigram.ca | 2013 | Moncton, Canada | Provider of cannabis products, brands, and international business development investments | |||
| cannara.ca | 2018 | Montreal, Canada | $17.66M | Medicinal cannabis cultivation facility |
Detailed competitors of PharmaCielo
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Pharmacielo
Complete news archive for PharmaCielo
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PharmaCielo
PharmaCielo was founded in 2014 and raised its 1st funding round 1 year after it was founded.
PharmaCielo is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Marc Lustig is the CEO of PharmaCielo, as recorded in our data.
PharmaCielo is a funded company, having raised a total of $16.44M across 10 funding rounds to date. The company's 1st funding round was a Seed of $686.25K, raised on May 2015.
Annual revenue of PharmaCielo is $1.82M as on Mar 31, 2026.
PharmaCielo was founded in 2014 and is headquartered in Toronto, Canada. Operations focus on the cultivation and marketing of medicinal cannabis in Colombia, where proprietary strains are grown under controlled indoor environments. Cannabis flowers are processed to extract oil and manufacture pharmaceutical-grade products for the health sector.
PharmaCielo's top competitors include Canopy Growth, Organigram and Cannara Biotech.
PharmaCielo offers CBD Isolate, Medicinal Flower, and Cannabis Extracts.
Yes, PharmaCielo is publicly traded on OTC under the ticker symbol PCLOF.
PharmaCielo has made 2 acquisitions, including Creso Pharma, and Ubiquo Telemedicina.
